The efficacy and safety of acupuncture for cerebral vasospasm after subarachnoid hemorrhage: study protocol for a randomized controlled trial

Seung-Yeon Cho, Dong-Hyuk Lee, Hee Sup Shin, Seung Hwan Lee, Jun Seok Koh, Woo-Sang Jung, Sang-Kwan Moon, Jung-Mi Park, Chang-Nam Ko, Ho Kim, Seong-Uk Park, Seung-Yeon Cho, Dong-Hyuk Lee, Hee Sup Shin, Seung Hwan Lee, Jun Seok Koh, Woo-Sang Jung, Sang-Kwan Moon, Jung-Mi Park, Chang-Nam Ko, Ho Kim, Seong-Uk Park

Abstract

Background: Subarachnoid hemorrhage (SAH) is a neurological disease with a high mortality rate. Several serious complications frequently arise after successful surgery for this condition. Cerebral vasospasm, one such complication, occurs in 50 to 70% of SAH patients. These patients suffer neurological symptoms known as delayed ischemic neurological deficit (DIND); however, the effect of treatment of vasospasm is limited. The major pathogenesis of cerebral vasospasm is the reduction of nitric oxide (NO) and activation of vasoconstrictors. Acupuncture is known to increase the production and activity of vascular endothelial cell-derived NO and improve endothelium-dependent vasodilatation. A preliminary retrospective case study to investigate the ability of acupuncture to prevent the occurrence of cerebral vasospasm has been conducted. However, no randomized, controlled clinical trials have been carried out to evaluate the efficacy of acupuncture for cerebral vasospasm.

Methods/design: This trial will be a single-center, randomized, placebo-controlled, parallel group, patient-assessor-blinded clinical trial. A total of 80 patients with SAH will be randomized into two groups: a study group given acupuncture, electroacupuncture, and intradermal acupuncture, and a control group given mock transcutaneous electrical nerve stimulation and sham intradermal acupuncture. Intervention will start within 96 h after SAH, and a total of 12 sessions will be performed during a 2-week period. The primary outcome measure will be the occurrence of DIND, and the secondary outcomes will be vasospasm as measured by cerebral angiography, transcranial Doppler, clinical symptoms, vasospasm-related infarcts, NO and endothelin-1 plasma levels, mortality, and modified Rankin Scale scores.

Discussion: This trial will examine the efficacy and safety of acupuncture for cerebral vasospasm after SAH. The placebo effect will be excluded and the mechanism of action of the treatments will be evaluated through blood testing.

Trial registration: ClinicalTrials.gov NCT02275949 , Registration date: 26 October 2014.

Figures

Figure 1
Figure 1
The flow chart. HHS, the Hunt and Hess Scale; FG, the Fisher grade; mRS, modified Rankin Scale; NO, nitric oxide; DIND, delayed ischemic neurological deficit.

References

    1. Aminmansour B, Ghorbani A, Sharifi D, Shemshaki H, Ahmadi A. Cerebral vasospasm following traumatic subarachnoid hemorrhage. J Res Med Sci. 2009;14:343–8.
    1. van Gijn J, Rinkel GJE. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124:249–78. doi: 10.1093/brain/124.2.249.
    1. Van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369:306–18. doi: 10.1016/S0140-6736(07)60153-6.
    1. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G, et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35:93–112. doi: 10.1159/000346087.
    1. Hobson C, Dortch J, Ozrazgat Baslanti T, Layon DR, Roche A, Rioux A, et al. Insurance status is associated with treatment allocation and outcomes after subarachnoid hemorrhage. PLoS One. 2014;9:e105124. doi: 10.1371/journal.pone.0105124.
    1. Plesnila N. Pathophysiological role of global cerebral ischemia following subarachnoid hemorrhage: the current experimental evidence. Stroke Res Treat. 2013;2013:e651958.
    1. Wilson SR, Hirsch NP, Appleby I. Management of subarachnoid haemorrhage in a non-neurosurgical centre. Anaesthesia. 2005;60:470–85. doi: 10.1111/j.1365-2044.2005.04152.x.
    1. Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–37. doi: 10.1161/STR.0b013e3182587839.
    1. Siasios I, Kapsalaki EZ, Fountas KN. Cerebral vasospasm pharmacological treatment: an update. Neurol Res Int. 2013;2013:e571328. doi: 10.1155/2013/571328.
    1. Keyrouz SG, Diringer MN. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11:220. doi: 10.1186/cc5958.
    1. Heiserman JE. MR angiography for the diagnosis of vasospasm after subarachnoid hemorrhage. Is it accurate? Is it safe? Am J Neuroradiol. 2000;21:1571–2.
    1. Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care. 2006;4:68–76. doi: 10.1385/NCC:4:1:068.
    1. Hanafy KA, Stuart RM, Khandji AG, Connolly ES, Badjatia N, Mayer SA, et al. Relationship between brain interstitial fluid tumor necrosis factor-? and cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Clin Neurosci. 2010;17:853–6. doi: 10.1016/j.jocn.2009.11.041.
    1. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction testing and clinical relevance. Circulation. 2007;115:1285–95.
    1. Østergaard L, Aamand R, Karabegovic S, Tietze A, Blicher JU, Mikkelsen IK, et al. The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2013;33:1825–37. doi: 10.1038/jcbfm.2013.173.
    1. Sobey CG, Faraci FM. Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol. 1998;25:867–76. doi: 10.1111/j.1440-1681.1998.tb02337.x.
    1. Hu H-H, Chung C, Liu TJ, Chen RC, Chen C-H, Chou P, et al. A randomized controlled trial on the treatment for acute partial ischemic stroke with acupuncture. Neuroepidemiology. 1993;12:106–13. doi: 10.1159/000110308.
    1. Chen S, Ma S-X. Nitric oxide in the gracile nucleus mediates depressor response to acupuncture (ST36) J Neurophysiol. 2003;90:780–5. doi: 10.1152/jn.00170.2003.
    1. Kim DD, Pica AM, Duran RG, Duran WN. Acupuncture reduces experimental renovascular hypertension through mechanisms involving nitric oxide synthases. Microcirc. 2006;13:577–85. doi: 10.1080/10739680600885210.
    1. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol. 2003;199:8–17. doi: 10.1002/path.1250.
    1. Li J, Li J, Chen Z, Liang F, Wu S, Wang H. The influence of PC6 on cardiovascular disorders: a review of central neural mechanisms. Acupunct Med. 2012;30:47–50. doi: 10.1136/acupmed-2011-010060.
    1. Rivas-Vilchis JF, Hernández-Sánchez F, González-Camarena R, Suárez-Rodríguez LD, Escorcia-Gaona R, Cervantes-Reyes JA, et al. Assessment of the vascular effects of PC6 (Neiguan) using the second derivative of the finger photoplethysmogram in healthy and hypertensive subjects. Am J Chin Med. 2007;35:427–36. doi: 10.1142/S0192415X07004941.
    1. Kim H-M, Cho S-Y, Park S-U, Sohn I-S, Jung W-S, Moon S-K, et al. Can acupuncture affect the circadian rhythm of blood pressure? A randomized, double-blind, controlled trial. J Altern Complement Med. 2012;18:918–23. doi: 10.1089/acm.2011.0508.
    1. Ko C-N, Lee I-W, Cho S-Y, Lee SH, Park S-U, Koh JS, et al. Acupuncture for cerebral vasospasm after subarachnoid hemorrhage: a retrospective case–control study. J Altern Complement Med. 2013;19:471–3. doi: 10.1089/acm.2012.0076.
    1. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20. doi: 10.3171/jns.1968.28.1.0014.
    1. Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care. 2005;2:110–8. doi: 10.1385/NCC:2:2:110.
    1. Dumont AS, Crowley RW, Monteith SJ, Llodiqwe D, Kassell NF, Mayer S, et al. Endovascular treatment or neurosurgical clipping of ruptured intracranial aneurysms; effect on angiographic vasospasm, delayed ischemic neurological deficit, cerebral infarction, and clinical outcome. Stroke. 2010;41:2519–24. doi: 10.1161/STROKEAHA.110.579383.
    1. Aaslid R, Huber P, Nornes H. Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg. 1984;60:37–41. doi: 10.3171/jns.1984.60.1.0037.
    1. Vora YY, Suarez-Almazor MMD, Steinke DE, Martin ML, Findlay JMMD. Role of Transcranial doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1999;44:1237–47.
    1. Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl (Wien) 1988;42:81–4.
    1. Shuster JJ. Practical handbook of sample size guidelines clinical trials MAC. Florida: CRC Press; 1992.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere